| Parkinsonism | ||
|
| Selegiline
(Eldepryl) is used in late Parkinsonism to enhance the
action of L-dopa and to reduce motor fluctuations. It is
also used in early disease due to a reported
neuroprotective effect with long term use. However, the
Parkinson's Research Group-UK recently noted a 10% higher
mortality in patients on Selegiline and L-dopa compared
to L-dopa patients without Selegiline. More research is
needed to clarify this matter. . |
Parkinsonism caused by any identifiable cause has to be treated. Drug induced parkinsonism responds to withdrawal of the drug but the symptoms may continue for some time. Drug therapy Anticholinergic agents Benxhexol
1-5 mg tid Have useful effect on tremor and rigidity. Do not help hypokynesis. They should be used in early stage of the disease when hypokynesis is not a problem. Side effects: dryness of mouth, blurring of vision, difficulty in micturation and constipation. Amantidine 100mg bid or tid It has mild short lived action on hypokinesis. Side effects: oedema, confution, seizures. L-DOPA The rationale for
using L-DOPA is that the enzyme step converting the
precursor DOPA to Dopamine is dependant on the
concentration of the substrate. Although in parkinsonism
the number of dopamine releasing terminals in the
striatum is diminished it is possible to overdrive the
remaining neurons to produce more dopamine by
administering DOPA. L-DOPA +
Carbidopa Bromocriptine is preferabley used as a low dose combination with L-DOPA. Especially in young patients who need treatment for many years. Surgery Stereotactic
thalamotomy is occationaly performed in patients with
severe unilateral tremors not responding to drugs. Physiotherapy and Speech therapy is needed to reduce rigidity and to correct posture.
Newer Treatment options for Parkinson's Disease |
|
![]() |
||